In 2019, a research group reported a method of expanding Hematopoietic Stem Cells over a long time period using a polymer-based culture system and cytokines which improved the earlier methods of gene editing. (Unsplash)
In 2019, a research group reported a method of expanding Hematopoietic Stem Cells over a long time period using a polymer-based culture system and cytokines which improved the earlier methods of gene editing. (Unsplash) 
Biotechnology

Hematopoietic Stem Cell Culture Technology for More Effective and Safer Genome Editing

MBT Desk

Hematopoietic stem cells (HSCs) are infrequent cells located in the marrow that generate red blood cells, white blood cells, and platelets. Their proper operation is vital for the development and well-being of an organism. Consequently, abnormalities in the genetic material of hematopoietic stem cells (mutations) can result in compromised blood generation and grave illnesses.

Hematopoietic system of the bone marrow: hematopoietic stem cells (HSCs) are rare cells found in the bone marrow. Defects in these can cause severe genetic diseases which can be treated with the help of gene editing. (Wikimedia commons)

Gene therapy aims to address such genetic disorders. A revolutionary technique that has revolutionized the entire domain in recent times is CRISPR/Cas9, an advanced method for gene editing through clustered regularly interspaced palindromic repeats/Cas9. By employing this approach, it becomes feasible to alter detrimental mutations and replace HSCs with restored functionality, potentially achieving a complete cure for the disease.

Nevertheless, the CRISPR/Cas9 system possesses imperfections. It solely rectifies mutations in a minute proportion of cells and may introduce fresh mutations that could be perilous into other cells. Consequently, the careful selection of corrected cells prior to transplantation becomes pivotal.

In 2019, the research team disclosed a technique for expanding HSCs extensively by employing a culture system based on polymers and cytokines. Addressing this issue, the authors have now devised an innovative culture system using a novel high-molecular-weight polymer. This system enables the proliferation of individual HSCs into transplantable cell colonies that exhibit a remarkable capacity for blood production after a prolonged period of ex vivo cultivation. Following the editing of a mutation in a mouse model with immune deficiency, the authors individually cultivate several hundred HSCs and meticulously examine them for clones exclusively carrying the desired genetic modification, ensuring successful engraftment. Through this method, the proportion of corrected HSCs suitable for transplantation can be elevated from 20%-30% to 100%, effectively eliminating potentially hazardous mutations from the graft. We strongly believe that this culture system holds the potential to enhance the efficiency and safety of genome editing in HSCs. (SD/Newswise)

Looking for an internship or volunteer opportunity or a job in the Medical and healthcare sector? Search at MedBound List: https://www.medbound.com/public-internship

B.Ed Student and City Bus Driver Die of Heart Attack in Indore

Another Mishap at Kozhikode MCH: Doctor Inserts Incorrect Rod Into Patient's Hand

Resident Doctor's Suicide in Dehradun Sparks Urgent Call for Medical Reforms

Crowdfunding for Rare Injection Worth Rs.17.5 Crores Helps Save Toddler’s Life

Metabolism-Related Health Issues Skyrocket: 50% Increase in Early Deaths and Poor Health Since 2000